Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19

Michael J Peluso; Amelia N. Deitchman; Leonel Torres; Nikita S. Iyer; Christopher C. Nixon; Sadie E. Munter; Joanna Donatelli; Cassandra Thanh; Saki Takahashi; Jill Hakim; Keirstinne Turcios; Owen Janson; Rebecca Hoh; Viva Tai; Yanel Hernandez; Emily A. Fehrman; Matthew A. Spinelli; Monica Gandhi; Lan Trinh; Terri Wrin; Christos J. Petroploulos; Francesca T. Aweeka; Isabel Rodriguez-Barraquer; J. Daniel Kelly; Jeffrey N. Martin; Steven G Deeks; Bryan Greenhouse; Rachel L. Rutishauser; Timothy J. Henrich.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-21252308

Documentos relacionados

  1. Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19.
  2. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
  3. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2.
  4. Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children.
  5. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.
  6. Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production.
  7. Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19.
  8. Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment.
  9. One-Year Sustained Cellular and Humoral Immunities in Coronavirus Disease 2019 (COVID-19) Convalescents.
  10. SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses.